IPCA Laboratories
Ashish Juneja is an experienced sales professional in the pharmaceutical industry, currently serving as National Sales Manager at Ipca Laboratories Limited since April 2023. Prior to this role, Ashish held the position of Business Head at Pulse Pharmaceuticals from January 2022 to March 2023. Ashish has also worked with MSN Laboratories from February 2015 to January 2022, initially as Sales Manager overseeing half of India's sales operations and later as Zonal Manager responsible for North India operations in the CNS division. Other notable positions include Zonal Head at MOLEKULE INDIA PVT. LTD and Sr. Regional Manager at Alkem Laboratories Ltd. Ashish’s career began at IPCA, where roles included Area Manager and Regional Manager. Ashish holds a Doctor of Pharmacy (PharmD) from the Punjab State Board of Technical Education and Industrial Training and a B.Sc. from Vinayaka Mission's Research Foundation - University.
This person is not in the org chart
This person is not in any teams
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.